{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:11:16Z","timestamp":1793319076658,"version":"4.5.0"},"reference-count":107,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2016,2,28]],"date-time":"2016-02-28T00:00:00Z","timestamp":1456617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Obese subjects often have hypertension and related cardiovascular and renal diseases, and this has become a serious worldwide health problem. In obese subjects, impaired renal-pressure natriuresis causes sodium retention, leading to the development of salt-sensitive hypertension. Physical compression of the kidneys by visceral fat and activation of the sympathetic nervous system, renin\u2013angiotensin systems (RAS), and aldosterone\/mineralocorticoid receptor (MR) system are involved in this mechanism. Obese subjects often exhibit hyperaldosteronism, with increased salt sensitivity of blood pressure (BP). Adipose tissue excretes aldosterone-releasing factors, thereby stimulating aldosterone secretion independently of the systemic RAS, and aldosterone\/MR activation plays a key role in the development of hypertension and organ damage in obesity. In obese subjects, both salt sensitivity of BP, enhanced by obesity-related metabolic disorders including aldosterone excess, and increased dietary sodium intake are closely related to the incidence of hypertension. Some salt sensitivity-related gene variants affect the risk of obesity, and together with salt intake, its combination is possibly associated with the development of hypertension in obese subjects. With high salt levels common in modern diets, salt restriction and weight control are undoubtedly important. However, not only MR blockade but also new diagnostic modalities and therapies targeting and modifying genes that are related to salt sensitivity, obesity, or RAS regulation are expected to prevent obesity and obesity-related hypertension.<\/jats:p>","DOI":"10.1093\/ajh\/hpw003","type":"journal-article","created":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T01:28:15Z","timestamp":1456795695000},"page":"415-423","source":"Crossref","is-referenced-by-count":145,"title":["The Role of Aldosterone in Obesity-Related Hypertension"],"prefix":"10.1093","volume":"29","author":[{"given":"Wakako","family":"Kawarazaki","sequence":"first","affiliation":[{"name":"Division of Clinical Epigenetics, Research Center for Advanced Science and Technology, The University of Tokyo 1 , Tokyo, Japan ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Fujita","sequence":"additional","affiliation":[{"name":"Division of Clinical Epigenetics, Research Center for Advanced Science and Technology, The University of Tokyo 1 , Tokyo, Japan ."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,2,28]]},"reference":[{"key":"2024012721425575400_CIT0001","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1467-789X.2009.00712.x","article-title":"The economic burden of obesity worldwide: a systematic review of the direct costs of obesity","volume":"12","author":"Withrow","year":"2011","journal-title":"Obes Rev"},{"key":"2024012721425575400_CIT0002","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10654-008-9239-1","article-title":"Health-economic burden of obesity in Europe","volume":"23","author":"M\u00fcller-Riemenschneider","year":"2008","journal-title":"Eur J Epidemiol"},{"key":"2024012721425575400_CIT0003","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1001\/jama.282.16.1523","article-title":"The disease burden associated with overweight and obesity","volume":"282","author":"Must","year":"1999","journal-title":"JAMA"},{"key":"2024012721425575400_CIT0004","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1161\/01.CIR.67.5.968","article-title":"Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study","volume":"67","author":"Hubert","year":"1983","journal-title":"Circulation"},{"key":"2024012721425575400_CIT0005","first-page":"155","article-title":"Health implications of obesity: an NIH Consensus Development Conference","volume":"9","author":"Burton","year":"1985","journal-title":"Int J Obes"},{"key":"2024012721425575400_CIT0006","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.2012.113905","article-title":"Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis","volume":"309","author":"Flegal","year":"2013","journal-title":"JAMA"},{"key":"2024012721425575400_CIT0007","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1210\/jc.2007-1088","article-title":"Body mass index predicts aldosterone production in normotensive adults on a high-salt diet","volume":"92","author":"Bentley-Lewis","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2024012721425575400_CIT0008","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/j.1550-8528.1999.tb00418.x","article-title":"Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women","volume":"7","author":"Goodfriend","year":"1999","journal-title":"Obes Res"},{"key":"2024012721425575400_CIT0009","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/HYPERTENSIONAHA.114.03936","article-title":"Circulating aldosterone and natriuretic peptides in the general community: relationship to cardiorenal and metabolic disease","volume":"65","author":"Buglioni","year":"2015","journal-title":"Hypertension"},{"key":"2024012721425575400_CIT0010","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1210\/jc.2003-030490","article-title":"50\n              th\n               anniversary of aldosterone","volume":"88","author":"Williams","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2024012721425575400_CIT0011","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.amjmed.2006.03.038","article-title":"Aldosterone blockade: an emerging strategy for abrogating progressive renal disease","volume":"119","author":"Epstein","year":"2006","journal-title":"Am J Med"},{"key":"2024012721425575400_CIT0012","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1097\/01.ASN.0000086472.65806.73","article-title":"Aldosterone in chronic kidney and cardiac disease","volume":"14","author":"Hostetter","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"2024012721425575400_CIT0013","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"2024012721425575400_CIT0014","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"2024012721425575400_CIT0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"2024012721425575400_CIT0016","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S2213-8587(14)70194-9","article-title":"Anti-albuminuric effect of the aldosterone blocker eplerenone in non-diabetic hypertensive patients with albuminuria: a double-blind, randomised, placebo-controlled trial","volume":"2","author":"Ando","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2024012721425575400_CIT0017","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/jama.2015.10081","article-title":"Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial","volume":"314","author":"Bakris","year":"2015","journal-title":"JAMA"},{"key":"2024012721425575400_CIT0018","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/S0140-6736(01)06710-1","article-title":"Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study","volume":"358","author":"Vasan","year":"2001","journal-title":"Lancet"},{"key":"2024012721425575400_CIT0019","doi-asserted-by":"crossref","first-page":"992","DOI":"10.7326\/0003-4819-140-12-200406150-00008","article-title":"Visceral adiposity is an independent predictor of incident hypertension in Japanese Americans","volume":"140","author":"Hayashi","year":"2004","journal-title":"Ann Intern Med"},{"key":"2024012721425575400_CIT0020","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/ajcn\/4.1.20","article-title":"The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease","volume":"4","author":"VAGUE","year":"1956","journal-title":"Am J Clin Nutr"},{"key":"2024012721425575400_CIT0021","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/archinte.168.15.1617","article-title":"The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999\u20132004)","volume":"168","author":"Wildman","year":"2008","journal-title":"Arch Intern Med"},{"key":"2024012721425575400_CIT0022","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.2337\/diacare.27.9.2222","article-title":"Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual","volume":"27","author":"St-Onge","year":"2004","journal-title":"Diabetes Care"},{"key":"2024012721425575400_CIT0023","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/(SICI)1099-0895(199703)13:1<3::AID-DMR178>3.0.CO;2-N","article-title":"Pathophysiology and molecular mechanisms of visceral fat syndrome: the Japanese experience","volume":"13","author":"Matsuzawa","year":"1997","journal-title":"Diabetes Metab Rev"},{"key":"2024012721425575400_CIT0024","doi-asserted-by":"crossref","first-page":"629","DOI":"10.5551\/jat.7922","article-title":"The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism","volume":"18","author":"Matsuzawa","year":"2011","journal-title":"J Atheroscler Thromb"},{"key":"2024012721425575400_CIT0025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cjca.2014.11.031","article-title":"Obesity and atherosclerosis: mechanistic insights","volume":"31","author":"Lovren","year":"2015","journal-title":"Can J Cardiol"},{"key":"2024012721425575400_CIT0026","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1681\/ASN.2006080944","article-title":"Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors","volume":"17","author":"Nagase","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"2024012721425575400_CIT0027","doi-asserted-by":"crossref","first-page":"14211","DOI":"10.1073\/pnas.2336140100","article-title":"Human adipocytes secrete mineralocorticoid-releasing factors","volume":"100","author":"Ehrhart-Bornstein","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024012721425575400_CIT0028","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1161\/01.HYP.0000113294.06704.64","article-title":"Epoxy-keto derivative of linoleic acid stimulates aldosterone secretion","volume":"43","author":"Goodfriend","year":"2004","journal-title":"Hypertension"},{"key":"2024012721425575400_CIT0029","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1096\/fj.07-9412com","article-title":"A novel adipokine CTRP1 stimulates aldosterone production","volume":"22","author":"Jeon","year":"2008","journal-title":"FASEB J"},{"key":"2024012721425575400_CIT0030","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1038\/oby.2005.263","article-title":"Meta-analysis on the G-308A tumor necrosis factor alpha gene variant and phenotypes associated with the metabolic syndrome","volume":"13","author":"Sookoian","year":"2005","journal-title":"Obes Res"},{"key":"2024012721425575400_CIT0031","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1046\/j.1365-2265.2003.01798.x","article-title":"The relation between two polymorphisms in the glucocorticoid receptor gene and body mass index, blood pressure and cholesterol in obese patients","volume":"59","author":"Di Blasio","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024012721425575400_CIT0032","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/ajh.2010.44","article-title":"Associations of the -344 T&gt;C and the 3097 G&gt;A polymorphisms of CYP11B2 gene with hypertension, type 2 diabetes, and metabolic syndrome in a French population","volume":"23","author":"Bellili","year":"2010","journal-title":"Am J Hypertens"},{"key":"2024012721425575400_CIT0033","doi-asserted-by":"crossref","first-page":"160","DOI":"10.14310\/horm.2002.1401","article-title":"Serum and glucocorticoid inducible kinase, metabolic syndrome, inflammation, and tumor growth","volume":"12","author":"Lang","year":"2013","journal-title":"Hormones (Athens)"},{"key":"2024012721425575400_CIT0034","doi-asserted-by":"crossref","first-page":"R935","DOI":"10.1152\/ajpregu.00382.2005","article-title":"Blunted hypertensive effect of combined fructose and high-salt diet in gene-targeted mice lacking functional serum- and glucocorticoid-inducible kinase SGK1","volume":"290","author":"Huang","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2024012721425575400_CIT0035","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1161\/01.HYP.0000052314.95497.78","article-title":"The kidney, hypertension, and obesity","volume":"41","author":"Hall","year":"2003","journal-title":"Hypertension"},{"key":"2024012721425575400_CIT0036","doi-asserted-by":"crossref","first-page":"49S","DOI":"10.1016\/S0895-7061(97)00075-7","article-title":"Mechanisms of abnormal renal sodium handling in obesity hypertension","volume":"10","author":"Hall","year":"1997","journal-title":"Am J Hypertens"},{"key":"2024012721425575400_CIT0037","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/CIRCRESAHA.116.305697","article-title":"Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms","volume":"116","author":"Hall","year":"2015","journal-title":"Circ Res"},{"key":"2024012721425575400_CIT0038","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/01.HYP.25.4.893","article-title":"Renal denervation attenuates the sodium retention and hypertension associated with obesity","volume":"25","author":"Kassab","year":"1995","journal-title":"Hypertension"},{"key":"2024012721425575400_CIT0039","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1161\/HYPERTENSIONAHA.109.141119","article-title":"Exposure to a high-fat diet alters leptin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits","volume":"55","author":"Prior","year":"2010","journal-title":"Hypertension"},{"key":"2024012721425575400_CIT0040","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/01.HYP.25.4.560","article-title":"Sympathetic activation in obese normotensive subjects","volume":"25","author":"Grassi","year":"1995","journal-title":"Hypertension"},{"key":"2024012721425575400_CIT0041","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1161\/01.CIR.96.10.3423","article-title":"Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects","volume":"96","author":"Vaz","year":"1997","journal-title":"Circulation"},{"key":"2024012721425575400_CIT0042","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0895-7061(01)01293-6","article-title":"Antihypertensive effect of alpha- and beta-adrenergic blockade in obese and lean hypertensive subjects","volume":"14","author":"Wofford","year":"2001","journal-title":"Am J Hypertens"},{"key":"2024012721425575400_CIT0043","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.111.185074","article-title":"Systemic and renal-specific sympathoinhibition in obesity hypertension","volume":"59","author":"Lohmeier","year":"2012","journal-title":"Hypertension"},{"key":"2024012721425575400_CIT0044","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1161\/CIRCULATIONAHA.108.824730","article-title":"Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in obesity-induced hypertension","volume":"119","author":"Nagae","year":"2009","journal-title":"Circulation"},{"key":"2024012721425575400_CIT0045","doi-asserted-by":"crossref","first-page":"R633","DOI":"10.1152\/ajpregu.00258.2005","article-title":"Physiology in perspective: The Wisdom of the Body. Neural control of the kidney","volume":"289","author":"DiBona","year":"2005","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2024012721425575400_CIT0046","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nm.2337","article-title":"Epigenetic modulation of the renal \u03b2-adrenergic-WNK4 pathway in salt-sensitive hypertension","volume":"17","author":"Mu","year":"2011","journal-title":"Nat Med"},{"key":"2024012721425575400_CIT0047","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1681\/ASN.2005111197","article-title":"Dietary electrolyte-driven responses in the renal WNK kinase pathway in vivo","volume":"17","author":"O\u2019Reilly","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"2024012721425575400_CIT0048","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00424-011-1062-y","article-title":"Dietary salt modulates the sodium chloride cotransporter expression likely through an aldosterone-mediated WNK4-ERK1\/2 signaling pathway","volume":"463","author":"Lai","year":"2012","journal-title":"Pflugers Arch"},{"key":"2024012721425575400_CIT0049","doi-asserted-by":"crossref","first-page":"7929","DOI":"10.1073\/pnas.1200947109","article-title":"Activation of the renal Na+:Cl- cotransporter by angiotensin II is a WNK4-dependent process","volume":"109","author":"Casta\u00f1eda-Bueno","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024012721425575400_CIT0050","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/ki.2008.451","article-title":"Dietary salt regulates the phosphorylation of OSR1\/SPAK kinases and the sodium chloride cotransporter through aldosterone","volume":"74","author":"Chiga","year":"2008","journal-title":"Kidney Int"},{"key":"2024012721425575400_CIT0051","doi-asserted-by":"crossref","first-page":"17271","DOI":"10.1074\/jbc.R110.113175","article-title":"Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins","volume":"285","author":"Hall","year":"2010","journal-title":"J Biol Chem"},{"key":"2024012721425575400_CIT0052","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199602013340503","article-title":"Serum immunoreactive-leptin concentrations in normal-weight and obese humans","volume":"334","author":"Considine","year":"1996","journal-title":"N Engl J Med"},{"key":"2024012721425575400_CIT0053","doi-asserted-by":"crossref","first-page":"H1219","DOI":"10.1152\/ajpheart.00796.2011","article-title":"The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome","volume":"302","author":"Putnam","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2024012721425575400_CIT0054","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s001090000144","article-title":"The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension","volume":"79","author":"Engeli","year":"2001","journal-title":"J Mol Med (Berl)"},{"key":"2024012721425575400_CIT0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2012.06.021","article-title":"Adipose tissue renin-angiotensin-aldosterone system (RAAS) and progression of insulin resistance","volume":"378","author":"Marcus","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"2024012721425575400_CIT0056","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11906-008-0019-9","article-title":"Local adipose tissue renin-angiotensin system","volume":"10","author":"Cassis","year":"2008","journal-title":"Curr Hypertens Rep"},{"key":"2024012721425575400_CIT0057","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/ajh.2009.263","article-title":"Adipose tissue-specific regulation of angiotensinogen in obese humans and mice: impact of nutritional status and adipocyte hypertrophy","volume":"23","author":"Yasue","year":"2010","journal-title":"Am J Hypertens"},{"key":"2024012721425575400_CIT0058","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1161\/HYPERTENSIONAHA.112.192690","article-title":"Adipocyte deficiency of angiotensinogen prevents obesity-induced hypertension in male mice","volume":"60","author":"Yiannikouris","year":"2012","journal-title":"Hypertension"},{"key":"2024012721425575400_CIT0059","first-page":"3925","article-title":"Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II","volume":"83","author":"Karlsson","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2024012721425575400_CIT0060","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1056\/NEJM198104163041602","article-title":"The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients","volume":"304","author":"Tuck","year":"1981","journal-title":"N Engl J Med"},{"key":"2024012721425575400_CIT0061","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0002-9149(86)90845-3","article-title":"Role for aldosterone in blood pressure regulation of obese adolescents","volume":"57","author":"Rocchini","year":"1986","journal-title":"Am J Cardiol"},{"key":"2024012721425575400_CIT0062","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/01.HYP.0000154361.47683.d3","article-title":"Weight loss and the renin-angiotensin-aldosterone system","volume":"45","author":"Engeli","year":"2005","journal-title":"Hypertension"},{"key":"2024012721425575400_CIT0063","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1381\/0960892053923734","article-title":"Morbid obesity, hypertensive disease and the renin-angiotensin-aldosterone axis","volume":"15","author":"Ruano","year":"2005","journal-title":"Obes Surg"},{"key":"2024012721425575400_CIT0064","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1016\/j.febslet.2006.06.034","article-title":"Tumor necrosis factor-alpha and interleukin-1beta increases CTRP1 expression in adipose tissue","volume":"580","author":"Kim","year":"2006","journal-title":"FEBS Lett"},{"key":"2024012721425575400_CIT0065","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1161\/CIRCULATIONAHA.115.018226","article-title":"Adipocyte-Derived Hormone Leptin Is a Direct Regulator of Aldosterone Secretion, Which Promotes Endothelial Dysfunction and Cardiac Fibrosis","volume":"132","author":"Huby","year":"2015","journal-title":"Circulation"},{"key":"2024012721425575400_CIT0066","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/HYPERTENSIONAHA.107.091058","article-title":"Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor: role of oxidative stress","volume":"50","author":"Nagase","year":"2007","journal-title":"Hypertension"},{"key":"2024012721425575400_CIT0067","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1161\/HYPERTENSIONAHA.108.111815","article-title":"Salt excess causes left ventricular diastolic dysfunction in rats with metabolic disorder","volume":"52","author":"Matsui","year":"2008","journal-title":"Hypertension"},{"key":"2024012721425575400_CIT0068","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1172\/JCI43124","article-title":"Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway","volume":"121","author":"Shibata","year":"2011","journal-title":"J Clin Invest"},{"key":"2024012721425575400_CIT0069","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1126\/science.2845584","article-title":"Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated","volume":"242","author":"Funder","year":"1988","journal-title":"Science"},{"key":"2024012721425575400_CIT0070","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1046\/j.1523-1755.2000.00978.x","article-title":"Role of the 11beta-hydroxysteroid dehydrogenase type 2 in blood pressure regulation","volume":"57","author":"Ferrari","year":"2000","journal-title":"Kidney Int"},{"key":"2024012721425575400_CIT0071","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1161\/hy1101.096112","article-title":"In vivo\n               11beta-HSD-2 activity: variability, salt-sensitivity, and effect of licorice","volume":"38","author":"Ferrari","year":"2001","journal-title":"Hypertension"},{"key":"2024012721425575400_CIT0072","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/BF03343752","article-title":"Urinary cortisol to cortisone metabolites in hypertensive obese children","volume":"23","author":"Cs\u00e1bi","year":"2000","journal-title":"J Endocrinol Invest"},{"key":"2024012721425575400_CIT0073","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1161\/HYPERTENSIONAHA.109.136242","article-title":"Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction","volume":"54","author":"Mihailidou","year":"2009","journal-title":"Hypertension"},{"key":"2024012721425575400_CIT0074","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10741-005-2349-x","article-title":"Effect of aldosterone and MR blockade on the brain and the kidney","volume":"10","author":"Stier","year":"2005","journal-title":"Heart Fail Rev"},{"key":"2024012721425575400_CIT0075","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1097\/00004872-199816121-00032","article-title":"Left ventricular systolic function in primary aldosteronism and hypertension","volume":"16","author":"Rossi","year":"1998","journal-title":"J Hypertens"},{"key":"2024012721425575400_CIT0076","first-page":"212","article-title":"Evidence of exercise-induced myocardial ischemia in patients with primary aldosteronism: the Cross-sectional Primary Aldosteronism and Heart Italian Multicenter Study","volume":"47","author":"Napoli","year":"1999","journal-title":"J Investig Med"},{"key":"2024012721425575400_CIT0077","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3181\/00379727-104-25782","article-title":"Protection by a steroid-spirolactone against certain types of cardiac necroses","volume":"104","author":"Selye","year":"1960","journal-title":"Exp Biol Med"},{"key":"2024012721425575400_CIT0078","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.RES.67.6.1355","article-title":"Remodeling of the rat right and left ventricles in experimental hypertension","volume":"67","author":"Brilla","year":"1990","journal-title":"Circ Res"},{"key":"2024012721425575400_CIT0079","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/jmcc.1993.1066","article-title":"Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism","volume":"25","author":"Brilla","year":"1993","journal-title":"J Mol Cell Cardiol"},{"key":"2024012721425575400_CIT0080","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/01.HYP.31.1.451","article-title":"Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats","volume":"31","author":"Rocha","year":"1998","journal-title":"Hypertension"},{"key":"2024012721425575400_CIT0081","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1161\/01.HYP.0000255636.11931.a2","article-title":"Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1","volume":"49","author":"Shibata","year":"2007","journal-title":"Hypertension"},{"key":"2024012721425575400_CIT0082","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1046\/j.1523-1755.2003.00929.x","article-title":"Aldosterone\/salt induces renal inflammation and fibrosis in hypertensive rats","volume":"63","author":"Blasi","year":"2003","journal-title":"Kidney Int"},{"key":"2024012721425575400_CIT0083","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.HYP.0000118519.66430.22","article-title":"Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone\/salt-induced hypertensive rats","volume":"43","author":"Nishiyama","year":"2004","journal-title":"Hypertension"},{"key":"2024012721425575400_CIT0084","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/01.HYP.0000067463.13172.EA","article-title":"Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension","volume":"41","author":"White","year":"2003","journal-title":"Hypertension"},{"key":"2024012721425575400_CIT0085","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.amjcard.2004.01.007","article-title":"Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension","volume":"93","author":"Williams","year":"2004","journal-title":"Am J Cardiol"},{"key":"2024012721425575400_CIT0086","doi-asserted-by":"crossref","first-page":"940","DOI":"10.2215\/CJN.00240106","article-title":"Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes","volume":"1","author":"Epstein","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"2024012721425575400_CIT0087","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1038\/sj.ki.5001854","article-title":"Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease","volume":"70","author":"Bianchi","year":"2006","journal-title":"Kidney Int"},{"key":"2024012721425575400_CIT0088","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1161\/01.HYP.0000044937.95080.E9","article-title":"Effectiveness of aldosterone blockade in patients with diabetic nephropathy","volume":"41","author":"Sato","year":"2003","journal-title":"Hypertension"},{"key":"2024012721425575400_CIT0089","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2215\/CJN.01040905","article-title":"Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker","volume":"1","author":"Chrysostomou","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"2024012721425575400_CIT0090","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1172\/JCI118709","article-title":"Obesity\/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance","volume":"97","author":"Steinberg","year":"1996","journal-title":"J Clin Invest"},{"key":"2024012721425575400_CIT0091","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1093\/eurheartj\/eht095","article-title":"Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity","volume":"34","author":"Sch\u00e4fer","year":"2013","journal-title":"Eur Heart J"},{"key":"2024012721425575400_CIT0092","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1210\/jc.2006-0736","article-title":"Insulin sensitivity in patients with primary aldosteronism: a follow-up study","volume":"91","author":"Catena","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2024012721425575400_CIT0093","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/dom.12224","article-title":"Effect of mineralocorticoid receptor antagonist on insulin resistance and endothelial function in obese subjects","volume":"16","author":"Garg","year":"2014","journal-title":"Diabetes Obes Metab"},{"key":"2024012721425575400_CIT0094","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1042\/CS20130200","article-title":"Mineralocorticoid receptors modulate vascular endothelial function in human obesity","volume":"125","author":"Hwang","year":"2013","journal-title":"Clin Sci (Lond)"},{"key":"2024012721425575400_CIT0095","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1096\/fj.06-7970com","article-title":"Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis","volume":"21","author":"Caprio","year":"2007","journal-title":"FASEB J"},{"key":"2024012721425575400_CIT0096","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1677\/JOE-09-0292","article-title":"The balance between gluco- and mineralo-corticoid action critically determines inflammatory adipocyte responses","volume":"204","author":"Hoppmann","year":"2010","journal-title":"J Endocrinol"},{"key":"2024012721425575400_CIT0097","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1126\/science.1066285","article-title":"A transgenic model of visceral obesity and the metabolic syndrome","volume":"294","author":"Masuzaki","year":"2001","journal-title":"Science"},{"key":"2024012721425575400_CIT0098","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.mce.2011.09.011","article-title":"The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism","volume":"350","author":"Marzolla","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"2024012721425575400_CIT0099","article-title":"Estimation of salt intake assessed by urinary excretion of sodium over 24h in Spanish subjects aged 7\u201311 years","author":"Aparicio","journal-title":"Eur J Nutr"},{"key":"2024012721425575400_CIT0100","first-page":"843","volume":"66","year":"2015"},{"key":"2024012721425575400_CIT0101","doi-asserted-by":"crossref","first-page":"e635","DOI":"10.1542\/peds.2013-1794","article-title":"Dietary sodium, adiposity, and inflammation in healthy adolescents","volume":"133","author":"Zhu","year":"2014","journal-title":"Pediatrics"},{"key":"2024012721425575400_CIT0102","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJM198908313210905","article-title":"The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents","volume":"321","author":"Rocchini","year":"1989","journal-title":"N Engl J Med"},{"key":"2024012721425575400_CIT0103","doi-asserted-by":"crossref","first-page":"e0120111","DOI":"10.1371\/journal.pone.0120111","article-title":"Gender-based differences on the association between salt-sensitive genes and obesity in Korean children aged between 8 and 9 years","volume":"10","author":"Lee","year":"2015","journal-title":"PLoS One"},{"key":"2024012721425575400_CIT0104","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.bbadis.2010.02.004","article-title":"Dopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation","volume":"1802","author":"Jose","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"2024012721425575400_CIT0105","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1373\/clinchem.2005.059139","article-title":"Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension","volume":"52","author":"Sanada","year":"2006","journal-title":"Clin Chem"},{"key":"2024012721425575400_CIT0106","doi-asserted-by":"crossref","first-page":"F298","DOI":"10.1152\/ajprenal.00362.2004","article-title":"Rosiglitazone restores renal D1A receptor-Gs protein coupling by reducing receptor hyperphosphorylation in obese rats","volume":"289","author":"Trivedi","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"2024012721425575400_CIT0107","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1291\/hypres.31.1455","article-title":"Effects of decreased renal cortical expression of G protein-coupled receptor kinase 4 and angiotensin type 1 receptors in rats","volume":"31","author":"Yatabe","year":"2008","journal-title":"Hypertens Res"}],"container-title":["American Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajh\/article\/29\/4\/415\/2622388","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article\/29\/4\/415\/2622388","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T21:43:54Z","timestamp":1706391834000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajh\/article\/29\/4\/415\/2622388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,28]]},"references-count":107,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,2,28]]},"published-print":{"date-parts":[[2016,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ajh\/hpw003","relation":{},"ISSN":["1941-7225","0895-7061"],"issn-type":[{"value":"1941-7225","type":"electronic"},{"value":"0895-7061","type":"print"}],"subject":[],"published-other":{"date-parts":[[2016,4]]},"published":{"date-parts":[[2016,2,28]]}}}